Results 81 to 90 of about 44,839 (230)

What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog

Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson, King Long Hannah Lee, Megan Dietz, Sarah Guess, Laura White, Mara S. Varvil   +5 more
wiley   +1 more source

A Case of Lisinopril‐Induced Hallucinations

Journal of General and Family Medicine, Volume 27, Issue 2, March 2026.
ABSTRACT Background Lisinopril is generally well tolerated, but rare neuropsychiatric adverse effects have been reported. Case We describe an 89‐year‐old woman who developed vivid nocturnal auditory and visual hallucinations approximately 3 months after starting lisinopril for hypertension.
Jack Golder, Julia Isom
wiley   +1 more source

Hyperkalemia and the Risks of Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This real‐world evidence study compared risks of cardiovascular events in hospital settings among patients with chronic kidney disease (CKD) with and without hyperkalemia.
Abiy Agiro, Fan Mu, Erin Cook, Alexandra Greatsinger, Jingyi Chen, Angela Zhao, Elaine Louden, Ellen Colman, Pooja Desai, Glenn M. Chertow   +9 more
doaj   +1 more source

The DYRK Family: A Key Regulator of Metabolic Homeostasis and Its Therapeutic Potential in Kidney Diseases

MedComm – Future Medicine, Volume 5, Issue 1, March 2026.
The DYRK family, a pivotal metabolic homeostasis regulator, mediates crosstalk between metabolic disorders and CKD via subtype‐specific mechanisms: DYRK1A drives diabetic (CKD risk), DYRK1B exacerbates metabolic renal injury, DYRK2 contributes to renal osteodystrophy, while DYRK3/4 remain unelucidated.
Yixuan Zhu, Pengfei Qiao, Yukun Gan, Xiushuo Fu, Xiayue Huang, Sirui Sun, Yafei Gou, Wenjie Xia, Feng Ma, Limin Liu   +9 more
wiley   +1 more source

Adrenal Crisis [PDF]

, 2019
Glucocorticoid replacement therapy, available since the 1950s, has prolonged the survival of patients with adrenal insufficiency. However, adrenal crises, which are life-threatening medical emergencies, still develop in many affected patients.
Falhammar, Henrik, Rushworth, R Louise, Torpy, David J   +2 more
core   +1 more source

Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial [PDF]

, 2016
Background—The prevalence of pre–diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known.
Cardoso, José Silva, Desai, Akshay S., Jhund, Pardeep S., Kristensen, Søren L., Lefkowitz, Martin P., Martinez, Felipe, McMurray, John J.V., Merkely, Bela, Packer, Milton, Preiss, David, Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Squire, Iain, Starling, Randall C., Swedberg, Karl, Zile, Michael R.   +17 more
core   +1 more source

Potential Drivers of Successful Biocontrol: A Perspective on Parasitoids

New Zealand Journal of Zoology, Volume 53, Issue 1, March 2026.
Parasitoids are central to classical biological control, yet predicting their long‐term effectiveness post release remains challenging. In Aotearoa New Zealand, three Microctonus (Hymenoptera: Braconidae) species have been used against pest weevils, but key aspects of their biology remain poorly understood.
Meeran Hussain, Elahe Parvizi, Mark R. McNeill, Ang McGaughran   +3 more
wiley   +1 more source

Polymorphisms in the WNK1 gene are asociated with blood pressure variation and urinary potassium excretion [PDF]

, 2009
WNK1 - a serine/threonine kinase involved in electrolyte homeostasis and blood pressure (BP) control - is an excellent candidate gene for essential hypertension (EH). We and others have previously reported association between WNK1 and BP variation. Using
Brown, M, Brunner, E, Burke, B, Cappucio, FP, Caulfield, M, Chambers, J, Clarke, R, Collins, R, Connell, JM, Dobson, R, Dominiczak, AF, Elliott, P, Eyheramendy, S, Farrall, M, Hoti, M, Howard, P, Iacone, R, Ji, C, Juhanson, P, Kooner, J, Kumari, M, Laan, M, Lathrop, GM, Lee, K, Marmot, M, Munroe, PB, Newhouse, S, Onipinla, A, Org, E, Samani, NJ, Shaw-Hawkins, S, Strazzullo, P, Veldre, G, Viigimaa, M, Wallace, C   +34 more
core  

Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate. [PDF]

, 2017
Hyperkalaemia is a life-threatening condition, resulting from decreased renal function or dysfunctional homoeostatic mechanisms, often affecting patients with cardiovascular (CV) disease.
Rosano, GMC, Spoletini, I, Agewall, S
core   +1 more source

Wenckebach Block due to Hyperkalemia: A Case Report

Emergency Medicine International, 2010
Hyperkalemia is a commonly encountered electrolyte abnormality that can significantly alter normal cardiac conduction. Potentially lethal dysrhythmias associated with hyperkalemia include complete heart block and Mobitz Type II second-degree AV block. We
Aparajita Sohoni, Berenice Perez, Amandeep Singh   +2 more
doaj   +1 more source